Monitoring is not diagnosis

A finger-stick meter may help selected patients observe trends between visits. It cannot confirm gout, exclude a joint infection, or decide whether medication should change. Unexpected or borderline results may need confirmation with a venous laboratory test.

Medication interference matters

Device instructions list limitations and potential interfering substances. For example, the FDA review for the UASure II system identifies medicines and substances that can affect results, including acetaminophen and ibuprofen at specified concentrations.

The GoutCura launch standard

The initial GoutCura framework is lab-guided control with clinician-ordered serum testing and optional home collection. A prescription meter would be a later add-on only for selected, diagnosed patients after device availability, medication screening, training, and a lab-confirmation protocol are established.

Primary and clinical sources

Read the evidence

GoutCura summarizes sources; it does not replace the full guideline, device labeling, or clinician judgment.

FDA UASure II 510(k) decision summaryFDA home uric-acid test classification